Skip to main content
Equibles

ADVENZYMES · Advanced Enzyme Technologies Limited · Financials

Use ADVENZYMES with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADVENZYMES.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
283.60 INR -0.50 (-0.18%) At close · Nov 13
Rebalance outlook locked
Market Cap
31.52B INR
Shares
111.15M
Volume · Nov 13 118.61K Avg daily vol (3M) 226.35K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
7.46B +17.1%
FY2026 Revenue FY2018–FY2026
Net Income
1.69B +28.7%
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
1.57B +10%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
INR 7.8B 7.46B 6.37B 6.24B 5.41B 5.29B 5.02B 4.44B 4.2B 3.96B
INR 411.73M 400.93M 365.56M 352.42M 350.29M 349.83M 284.12M 257.78M 211.16M 182.98M
INR 29.03M 26.28M 35.57M 29.28M 24.21M 17.96M 15.94M 30.36M 38.7M 80.86M
INR — 2.33B 1.87B 1.88B 1.4B 1.71B 2.1B 1.79B 1.62B 1.39B
INR 621.83M 589.28M 533.9M 508.7M 365.22M 472.59M 589.07M 461.08M 460.61M 454.11M
INR 1.71B 1.69B 1.31B 1.33B 1.06B 1.2B 1.46B 1.29B 1.11B 900.55M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 1.88B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.